story of the week
Neoadjuvant Carboplatin in Early Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Neoadjuvant Carboplatin in Patients With Triple-Negative and HER2-Positive Early Breast Cancer (GeparSixto; GBG 66): A Randomised Phase 2 Trial
Lancet Oncol 2014 Jun 01;15(7)747-56, G von Minckwitz, A Schneeweiss, S Loibl, C Salat, C Denkert, M Rezai, JU Blohmer, C Jackisch, S Paepke, B Gerber, DM Zahm, S Kümmel, H Eidtmann, P Klare, J Huober, S Costa, H Tesch, C Hanusch, J Hilfrich, F Khandan, PA Fasching, BV Sinn, K Engels, K Mehta, V Nekljudova, M UntchFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.